Akimichi Morita

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Janyerkye Tulyeu

Osaka University

JAPAN

View details

Tadashi Terui

JAPAN

View details

Howard Sofen

Health Science Clinical Professor

Olive View-UCLA Medical Center

UNITED STATES

View details

Mara Llamas-Covarrubias

Specially Appointed Assistant Professor

Osaka University

JAPAN

View details

Hidehisa Saeki

Professor

Nippon Medical School

JAPAN

View details

Daisuke Sugiyama

Senior Lecturer

Nagoya University

JAPAN

View details

Frauke Becker

Professor

Hochschule Rhein-Waal

GERMANY

View details

Yukari Okubo

JAPAN

View details

Bruce Strober

Clinical Professor

Yale University School of Medicine

UNITED STATES

View details

T. Passeron

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Akimichi Morita

Research Interests

Explore related searches

Contact this professor

Articles (30)

Human precursor T follicular regulatory cells are primed for differentiation into mature Tfr and disrupted during severe infections.

Prospective, Open‐Label, Multicenter Study of Apremilast as Maintenance Therapy for Psoriasis Patients in Remission With Biologics

Postoperative Complications and Risk Factors in Skin Tumor Excision With Simple Suturing Under Local Anesthesia: A Multicenter Retrospective Study in Japan

A Large‐Scale, Retrospective Analysis of Bath‐Psoralen Plus Ultraviolet A Therapy for Psoriasis: A Single‐Center Study

The Skin−Brain Dialogue: Advancing Psychodermatology Through Integrated Approaches

Quantitative Evaluation of Successful Combination Therapy With Dye Laser and Long‐Pulse Alexandrite Laser for Papulopustular Rosacea

Questionnaire Survey on the Treatment of Psoriasis Patients Who Achieved Remission With Biologics

Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 POETYK PSO‐1, PSO‐2 and long‐term extension trials

UVB Irradiation Expands Skin-Resident CD81+Foxp3+ Regulatory T Cells with a Highly Activated Phenotype

Clinical Characteristics and Safety Profiles of Japanese Psoriasis Patients Who Continued Apremilast Treatment for 6 and 12 Months: A Post Hoc Analysis of an Apremilast Postmarketing Surveillance Study

Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials

Comparative analysis of one‐step and two‐step full thickness skin grafting and secondary intention healing for skin defects after surgical management of plantar malignant melanoma

Expert consensus on systemic therapy for plaque psoriasis with limited skin involvement in JAPAN: Results from a DELPHI study

Deucravacitinib in moderate‐to‐severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO‐1 and PSO‐2)

Attitudes and behaviors regarding sun exposure in Japan compared to Europe and North America

Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study

Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post‐marketing surveillance study

Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1

Differences in the clinical presentation of necrotizing fasciitis depending on the causative pathogen

Specific dermoscopic findings in glomeruloid haemangioma for diagnosis of <scp>POEMS</scp> syndrome

Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study

Sun exposure behaviours as a compromise to paradoxical injunctions: Insight from a worldwide survey

Real‐world retention rates and effectiveness of secukinumab in psoriasis: Results from a multicenter cohort study (RAILWAY)

Clinical Outcomes of Radiation Therapy for Angiosarcoma of the Scalp and Face: A Multi-Institutional Observational Study

Impact of body mass index on the severity of bexarotene‐associated hypertriglyceridemia: A post hoc analysis of an open‐labeled clinical study of combined bexarotene and phototherapy in Japanese patients with cutaneous T‐cell lymphoma

Assessment of flare frequency and severity of generalized pustular psoriasis in Japanese patients: A retrospective chart review study

Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double‐blind, placebo‐controlled, global phase 3 trial

Spesolimab improves patient‐reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study

Influence of aldo–keto reductase 1C3 polymorphisms in early-onset female psoriasis patients

Collaborators (10)

Janyerkye Tulyeu

Tadashi Terui

Howard Sofen

Mara Llamas-Covarrubias

Hidehisa Saeki

Daisuke Sugiyama

Frauke Becker

Yukari Okubo

Bruce Strober

T. Passeron

Make your next move.